Antigen Presentation Inhibitors for Cancer Immunotherapy 2021 ASPIRE Award Jun Wang, PhD (Principal) and Iannis Aifantis, PhD, New York University Read More
Characterizing and Targeting Inflammation in RUNX1-Mutant Cancer Progression 2021 PARTNERSHIP WITH RUNX1 RESEARCH PROGRAM Ravi Majeti, MD, PhD, Stanford University Read More
Inflammation and Predisposition to Familial Platelet Disorder and Hematologic Malignancies 2021 PARTNERSHIP WITH RUNX1 RESEARCH PROGRAM Lucio Castilla, PhD, University of Massachusetts Medical School Read More
Delineating the Epigenetic Landscape and Pro-Inflammatory Gene Expression Program Associated with RUNX1 Familial Platelet Disorder 2021 PARTNERSHIP WITH RUNX1 RESEARCH PROGRAM Lucy Godley MD, PhD, University of Chicago Read More
CRCbioscreen 2021 Program Related Investment Gerrit Meijer, MD, PhD, the Netherlands Cancer Institute Read More
Novel EGFR Inhibitors for Non-Small Cell Lung Cancer 2021 Drug Discovery Award Michael Eck, MD, PhD, Pasi Jänne, MD, PhD, and David Scott, PhD, Dana-Farber Cancer Institute Read More